NABsys is developing its proprietary Hybridization-Assisted Nanopore Sequencing (HANS) platform. This platform combines bleeding edge technology in physics, biochemistry, and computer science to sequence DNA in a way that is projected to be orders of magnitude cheaper and faster than any technology available today.
Nano Bridging Molecules is devoted to researching, developing, manufacturing, and marketing its patented SurfLink® range of advanced medical implant surface modifications designed to render medical implants biocompatible with the human body.
Nano Med Tech is a biomedical research organization with its primary facility in Shanghai, China. The organization focuses on human application of nano-technology, particularly in the field of cancer treatment.
The company manufactures the Bio-Assembler, a device for culturing cells in three-dimensions by magnetic levitation. The Bio-Assembler combines nanoparticle based Nanoshuttle-PL with designed magnetic fields needed to levitate cells and provide the 3D cell growth environment.
Nanocopoeia is a therapeutic particle engineering company providing nano-enabled particle design, services, and equipment to the pharmaceutical industry. Their patented ElectroNanospray™ (ENS) process is used to produce homogeneous nanoparticles in a unique one-step continuous process. They have the ability to engineer multicomponent particles. ENS is a non-destructive process operating at ambient temperature and pressure. The modular equipment design allows for easy entry at R&D scale moving to pilot and full scale production.
NanoCor intends to use its proprietary Biological Nanoparticle technology platform and a proprietary, patent-protected gene to provide Chronic Heart Failure patients worldwide with an effective, economic, and safe alternative.
NanoDrop Technologies manufactures and sells unique analytical instruments based upon patented sample retention technology. These instruments are used globally in biotechnology, pharmaceutical and life science research.
Nanofiber Solutions designs and manufactures novel 3D nanofiber scaffolds. The company's 3D cell culture products NanoAligned and NanoECM were developed for life science research. Nanofiber Solutions novel platform technology provides researchers with more biologically realistic 3-dimensional in vivo cell culture environment.
Nanogea is a nano-bioscience company focused on commercializing the industry's most sensitive single molecular detection platform based on its innovative NanoCone™ chemistry and NanoCone Enabled Atomic Force (NE-AFMTM) technology.
Nanoimmunotech is a Spanish company in the Nanobiotechnology sector, founded in August 2009, recognized as EIBT (Technologically Innovative Company) and Spin-off of form the Universities of Vigo and Zaragoza. It is the first European company dedicated to the biological and physico-chemical characterization and functionalization of nanoparticles (conjugation with different molecules such as nucleid acids, enzimes, antibodies, carbohydrates, peptides) and production of specific monoclonal antibodies (on demand).
NanoLight Technologies is a division of Prolume Ltd., a biotechnology company developing broad applications of natural, light-emitting marine proteins, or marine bioluminescence. The NanoLight division is focused on becoming the leader in high-value reagent & reporter systems for new product development in the pharmaceutical, agrichemical, and research products industries.
NanoMedical Systems (NMS) is a startup company, which will commercialize the patented research of Dr. Mauro Ferrari at the University of Texas Health Science Center in Houston, a sponsored research site and a source of licensed IP for NMS. The company's Personalized Molecular Drug-delivery System (PMDS) is a small drug delivery device that is implanted subcutaneously (just under the skin) for slow and consistent release of a therapeutic agent over many weeks or months. A nanochannel delivery system (nDS) embodied on a silicon chip regulates the flow of therapeutic molecules.